Volume
Open
Day's Low
Day's High
52 Wk Low
52 Wk High
Bid
Ask
EPS
PE Ratio
Shares
Market Cap
Dividend
Ex-Div Date
Yield
Interested in Gold Updates?
Receive the latest updates on the gold and silver markets.
...
Health Technology » Biotechnology
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| VTL | Vital Therapies, Inc. | 1.50% | 13.51 | 3.3% | $792.68m | |
| AMGN | Amgen Inc. | -1.31% | 203.31 | 1.3% | $763.34m | |
| GILD | Gilead Sciences, Inc. | -1.01% | 63.47 | 0.9% | $384.47m | |
| CELG | Celgene Corporation | 0.15% | 95.36 | 1.3% | $349.24m | |
| BIIB | Biogen Inc. | -1.99% | 231.04 | 1.3% | $303.18m | |
| ILMN | Illumina, Inc. | -1.07% | 285.57 | 3.5% | $300.60m | |
| VRTX | Vertex Pharmaceuticals Incorporated | -2.19% | 182.99 | 1.9% | $261.18m | |
| EXAS | Exact Sciences Corporation | 1.38% | 119.79 | 24.1% | $251.43m | |
| ALXN | Alexion Pharmaceuticals, Inc. | -0.84% | 111.73 | 2.0% | $248.85m | |
| REGN | Regeneron Pharmaceuticals, Inc. | -0.74% | 296.16 | 2.6% | $215.44m | |
| A | Agilent Technologies, Inc. | -0.75% | 71.21 | 1.6% | $204.96m | |
| SRPT | Sarepta Therapeutics, Inc. | -17.21% | 99.61 | 14.7% | $127.38m | |
| INCY | Incyte Corporation | -0.71% | 83.92 | 2.5% | $99.55m | |
| BMRN | BioMarin Pharmaceutical Inc. | -1.68% | 76.11 | 4.3% | $93.12m | |
| GHDX | Genomic Health, Inc. | 0.08% | 74.28 | 1.8% | $90.50m |
Company Profile
ImmunoGen, Inc. is a biotechnology company, which engages in discovering and developing antibody-drug conjugate therapies that meaningfully improve the lives of people with cancer. Its product candidates include Mirvetuximab soravtansine, Coltuximab ravtansine, IMGN7779 and IMGN632. The company was founded in March 1981 and is headquartered in Waltham, MA.